No Data
Express News | Japan Health Ministry Panel Endorses Biogen's ALS Drug Tofersen, Kyodo Says
RBC Capital Sticks to Its Buy Rating for Biogen (BIIB)
Eisai, Biogen Launch Leqembi in South Korea
Wednesday Ends With Index Decline | Wall Street Today
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Why Is Biogen Inc. (BIIB) Among the Worst Performing Healthcare Stocks in 2024?